Conceivex
Conceivex manufactures the FDA 510(k)-cleared Conception Kit at-home fertility system, sold by prescription through US retail pharmacies and telemedicine. The three-month kit combines a patented silicone cervical cap with ovulation predictors and accessories to address male and female factor infertility in non-clinical settings.
- Company typePrivate
- Founded2015
- HeadquartersBloomfield Hills, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Conceivex does
Conceivex, Inc. is a Michigan-incorporated, privately held medical device company that designs, manufactures, and distributes the FDA 510(k)-cleared Conception Kit at-home system for fertility treatment. The company was founded by Michael La Vean and operates from Bloomfield Hills, Michigan, with 11-50 employees and is governed by a Board of Directors that includes Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan.
The company's core technology is the Conception Cap, a one-size-fits-most, FDA-cleared cervical cap made from soft, implantable-grade silicone (General Electric Silopren, also used in heart replacement valves) with a patented collapsible dome that concentrates semen at the cervical os and a built-in removal loop. The cap is paired with a patented latex-free Semen Collector, a sperm-friendly intimate moisturizer, an ovulation predictor system (24 tests timed to the LH surge), a practice cap, pregnancy tests, a conception wheel, a journal, and an instruction manual to deliver a complete three-month treatment cycle. The mechanism addresses male-factor infertility (low count, low motility) and female-factor issues (hostile vaginal environment, cervix positioning) by protecting sperm from the vaginal pH environment where 90% of sperm reportedly die within 10 minutes during normal intercourse. FDA clearance demonstrated 24% conception in the first month of clinical use, 92% patient comprehension of instructions, and 84% ease-of-use rating; historical cervical cap efficacy ranges cited are 18-44%.
Conceivex operates a prescription-based hybrid B22C commercial model exclusively in the United States. Patients obtain prescriptions from physicians or through the eVisit telemedicine platform in select states, then fill the kit at major retail pharmacies (Walgreens, Walmart, Target, Rite Aid, HealthWarehouse.com) under standard pharmacy benefit coverage with co-pays reported as $0-$50, or purchase directly from Conceivex for a $399 out-of-pocket price with HSA/FSA eligibility. Target segments include couples in the initial 12 months of trying to conceive, men with low sperm count or motility, single mothers by choice, religious couples declining ART, military couples with limited conception windows, and women on fertility medication cycles seeking to maximize each cycle. There is no parent company, no public listing, no disclosed M&A activity, and one disclosed capital event of $2.55M dated 2015-08-25.
Conceivex firmographics
Firmographics- Name
- Conceivex
- Legal name
- Conceivex, Inc.
- Website
- https://conceptionkit.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Conceivex manufactures the FDA 510(k)-cleared Conception Kit at-home fertility system, sold by prescription through US retail pharmacies and telemedicine. The three-month kit combines a patented silicone cervical cap with ovulation predictors and accessories to address male and female factor infertility in non-clinical settings.
- Ownership category
- akta.pro rank
Conceivex industry classification
Industry- Product category
- Fertility Medical Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)
- akta.pro secondary industry
- Fertility & Ovulation Products (OTC) (CRABAIAK)
Keywords
Where Conceivex is headquartered
LocationHeadquarters
- HQ city
- Bloomfield Hills
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Conceivex business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Conception Kit Product Sales: One-time purchase of three-month Conception Kit at-home system; sold through pharmacies with insurance coverage (low copay) or direct purchase for out-of-pocket; prescription required in the United States; HSA and FSA eligible.
- Pharmacy Benefit: Kit covered under normal pharmacy benefit plans (not fertility rider); can be used during initial 12 months of trying to conceive; patients covered have co-pays as low as $25-$50.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Out-of-pocket purchase - three month supply |
| Subscription | Monthly | Insurance pharmacy benefit - three month supply |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Conceivex product offering
Product offeringCore offering
Conceivex manufactures and distributes the Conception Kit at-home fertility treatment system, a three-month FDA 510(k)-cleared medical device that combines a cervical cap insemination device with ovulation predictors, a semen collector, and a sperm-friendly lubricant to help couples conceive naturally at home. The product is sold by prescription through US retail pharmacies and directly from the company, priced at $399 out-of-pocket or $0-$50 insurance copay as a covered pharmacy benefit.
Product overview
Conceivex manufactures and distributes the Conception Kit® at-home system, a single unified FDA-cleared medical device for at-home fertility treatment. The product is a three-month comprehensive system that combines cervical cap insemination with timed intercourse to help couples overcome infertility. The kit includes the Conception Cap® (FDA-cleared cervical cap), Practice Conception Cap®, Conceivex Semen Collector, Conceivex Ovulation Predictors (24 tests), Sperm-Friendly Intimate Moisturizer, Pregnancy Tests, Conception Journal, Conception Wheel, and Instruction Manual. The Conception Kit is available by prescription only and covered by many insurance plans as a pharmacy benefit.
Differentiator
Problem solved
Functional benefit
Brands
- Conception Kit®: The primary at-home system for couples trying to conceive, combining cervical cap insemination with ovulation timing. FDA-cleared for low sperm count, low sperm motility, and hostile vaginal environment.
- Conception Cap®
- Conceivex Ovulation Predictors
Products and services
- Conception Kit At-Home System Three-month comprehensive at-home fertility treatment system combining a cervical cap insemination device with ovulation timing tools. FDA 510(k) cleared for low sperm count, low sperm motility, and hostile vaginal environment. Sold by prescription through US retail pharmacies or directly from Conceivex.
Quantifiable outcome
- 24% conception rate in first month of use in clinical trial
- +5 more outcomes
Companies that use Conceivex
Customer profileNamed customers3 records
Segments7 records
Ideal customer profiles2 records
Conceivex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Conceivex partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- eVisitcoreTelemedicine integration partnership allowing patients to connect with OB/GYNs via secure video consultation for prescriptions; available in select states with expansion ongoing; enables remote prescription acquisition without in-person doctor visits
Scale indicators4 records
Recent moves4 records
Expansion highlights3 records
Conceivex competitors and assessment
Company assessmentDirect peers
- First Response: Church & Dwight's First Response brand sells OTC ovulation and pregnancy tests in the same retail pharmacy channels (Walgreens, Target, Walmart, Rite Aid) as the Conception Kit, targeting the same end-customer segment of couples trying to conceive.
- Clearblue: Clearblue (Swiss Precision Diagnostics) is a leading OTC ovulation and pregnancy test brand sold across major US retail pharmacies, directly competing for the same conception-timing wallet share that the Conception Kit's ovulation predictors address.
- Stork OTC (Rinovum Women's Health): Rinovum previously commercialized Stork OTC, a competing at-home conception aid device targeting the same low-cost, non-clinical first-step positioning as the Conception Kit, making it the closest historical direct competitor in the at-home cervical-cap-style category.
Emerging players
- Mira: Mira sells at-home quantitative fertility hormone monitors that compete with the Conception Kit's ovulation predictors as a more high-tech, app-connected alternative for couples trying to conceive naturally.
- Ava: Ava's wearable fertility tracker targets the same trying-to-conceive segment via continuous cycle monitoring, offering a non-device, non-prescription alternative that could substitute for the timing function in the Conception Kit.
- Modern Fertility (Ro): Modern Fertility (acquired by Ro) sells at-home fertility hormone tests targeting women trying to conceive, addressing the same pre-treatment diagnostic step that often precedes OB/GYN referral to the Conception Kit.
- Proov: Proov markets at-home PdG (progesterone metabolite) tests for ovulation confirmation, competing for the same ovulation-timing consumer education dollars and shelf space as the Conceivex Ovulation Predictors.
- Natalist: Natalist is a DTC women's reproductive health brand selling fertility-support products, ovulation tests, and prenatal supplements to the same target demographic of couples in the early stages of trying to conceive.
Broad incumbents
- Church & Dwight: Church & Dwight owns First Response and broader personal care brands, giving it established mass-market retail distribution and marketing scale that could be leveraged to enter the at-home conception aid category if it became attractive enough.
Others
- Fairhaven Health: Fairhaven Health sells fertility supplements and related products to couples trying to conceive, operating in an adjacent (nutraceutical) rather than device category but serving the same end customer and overlapping with the Conceivex content-marketing funnel.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Conceivex social profiles
Digital presenceConceivex compliance and trust
Trust signalCompliance1 record
Conceivex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Conceivex leadership team
Management profileNumber of profiles
Profiles4 records
Conceivex funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Conceivex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Conceivex
What does Conceivex do?
Conceivex manufactures and distributes the Conception Kit at-home fertility treatment system, a three-month FDA 510(k)-cleared medical device that combines a cervical cap insemination device with ovulation predictors, a semen collector, and a sperm-friendly lubricant to help couples conceive naturally at home. The product is sold by prescription through US retail pharmacies and directly from the company, priced at $399 out-of-pocket or $0-$50 insurance copay as a covered pharmacy benefit.
Is Conceivex a public or private company?
Conceivex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Conceivex founded?
Conceivex was founded in 2015. It employs 11 to 50 people.
Where is Conceivex based?
Conceivex is headquartered in Bloomfield Hills, United States, in the North America region.
How does Conceivex make money?
Two revenue lines are on record. Conception Kit Product Sales are the primary driver. The others are pharmacy Benefit.
Who are Conceivex's main competitors?
Direct peers on record are First Response, Clearblue and Stork OTC (Rinovum Women's Health). Emerging players are Mira, Ava, Modern Fertility (Ro), Proov and Natalist. Church & Dwight is listed as a broad incumbent. Fairhaven Health is listed as an others.
Does Conceivex have an API?
No public API is recorded for Conceivex.
What industry is Conceivex in?
Conceivex's product category is Fertility Medical Devices. Its primary akta.pro industry code is HLAHANAG, Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs), with a secondary code of CRABAIAK, Fertility & Ovulation Products (OTC). Its NAICS code is 3391 and its SIC code is 3841.